Home . Immediapress . Chimica e Farmacia . First Publication of HemaSphere, the New Journal of the European Hematology Association, Now Online

First Publication of HemaSphere, the New Journal of the European Hematology Association, Now Online

CHIMICA E FARMACIA

THE HAGUE, Netherlands, December 21, 2017 /PRNewswire/ --

HemaSphere, the new open access journal of the European Hematology Association (EHA),was published on December 20.

     (Logo: http://mma.prnewswire.com/media/524821/EHA_Logo.jpg )

HemaSphere is an open access journal, powered by the European Hematology Association and dedicated to support hematology patient care, research and education worldwide.

HemaSphere aims to be the premier hematology information resource combining scientific articles with EHA updates and insightful discussions on all aspects related to hematology. The journal welcomes commentaries on recent publications, reports on new therapies, articles on politics and policy from an EU perspective and the latest news on hematology. An innovative and fast peer-review process is used to select the manuscripts of the highest quality.

Be one of the first to see the maiden issue of HemaSphere on http://www.hemaspherejournal.com . The Next issue will be available in February 2018.

About the European Hematology Association  

The European Hematology Association (EHA) promotes excellence in patient care, research and education in hematology.

EHA envisions a world without blood disorders by connecting hematologists worldwide, supporting their career development and research, harmonizing hematology education and advocating the interests of hematology and hematologists in the European arena.

With more than 4,000 members from 100+ countries, EHA is Europe's largest professional organization supporting both clinicians and scientists around the globe in their efforts to cure blood diseases.

For more information about our organization, activities and advocacy, please visit http://www.ehaweb.org or follow us on Facebook (EuropeanHematologyAssociation), LinkedIn (EHA) and Twitter (@EHA_hematology).

RIPRODUZIONE RISERVATA © Copyright Adnkronos.